As pharmaceutical companies expand direct-to-patient (DtP) and home delivery models for specialty, biologic, and temperature-sensitive therapies, supply chains are being forced to evolve beyond traditional distribution frameworks. Delivering therapies directly to patients introduces an entirely new level of operational complexity around temperature control, visibility, patient communication, delivery coordination, packaging, and risk management, all while maintaining compliance and ensuring a seamless patient experience.

This session will explore the operational realities of building patient-centric cold chain models, including how organizations are redesigning logistics networks, leveraging digital tools, and partnering across the ecosystem to safely and reliably deliver therapies directly to patients' homes.